Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
+0.0010 (11.11%)
Apr 22, 2025, 4:00 PM EDT
Evofem Biosciences Company Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.
The company’s commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis.
Evofem Biosciences, Inc. is headquartered in San Diego, California.
Evofem Biosciences, Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Saundra Pelletier |
Contact Details
Address: 7770 Regents Road San Diego, Delaware 92122 United States | |
| Phone | 858 550 1900 |
| Website | evofem.com |
Stock Details
| Ticker Symbol | EVFM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US30048L2034 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Saundra Pelletier | Interim Chair, President and Chief Executive Officer |
| Ivy Zhang CPA | Chief Financial Officer and Secretary |
| Ellen Thomas | Chief of Staff |
| Amy Raskopf | Chief Business Development Officer |
| Kathy Gallo-Doyle | Senior Vice President of Commercial Operations |